Tiny Gem

GEMXX Corp. (GEMZ) On Track to Exceed Estimated Production for the Season Following 2nd Clean-Out and Recording of Gold Production at Snow Creek Mine Site

  • GEMXX Corp., producer and distributor of gold and gems, draws on its own mining assets to manufacture its colorful jewelry, unique in the jewelry industry, and is the leading producer of top-quality finished Ammolite products.
  • GEMXX just completed its second clean-out and recording of gold production at its Snow Creek Mine site, yielding 172.3 ounces of gold from 18,000 cubic yards of material, resulting in 0.96 ounces per 100 cubic yards.
  • 2023 gold production is a huge milestone for the company, as it looks to de-risk its revenues and complement its Ammolite production, and the company is on track to exceed its estimated gold production for the 2023 mining season

GEMXX (OTC: GEMZ), a publicly traded company specializing in producing and distributing gemstones and jewelry globally, is on track to exceed its estimated production for the 2023 mining season. This follows the recent successful completion of its second clean-out and recording of gold production at its Snow Creek Mine site, which yielded 172.3 ounces of gold from 18,000 cubic yards of material, resulting in 0.96 ounces per 100 cubic yards (https://ibn.fm/o5xVm).

This was the product of its ongoing collaboration with Crazy Horse Mining, Inc. (“CHMI”), in which GEMXX completed the acquisition of a 50% interest back in March 2023. The objective for the acquisition was to grow GEMXX’s long-term asset expansion plan, coupled with its goal to de-risk revenues, which the results achieved so far bring the company closer to achieving.

“Gold production from the Snow Creek mine helps to de-risk revenues, but most importantly, it complements our Ammolite production with the world’s most sought-after commodity,” noted Jay Maull, GEMXX’s CEO.

This further complements the company’s goal of expanding its gemstone and jewelry production by 300% year-over-year in response to growing demand. Already, the company, through its shopping channel division, is preparing to supply $5.5 million worth of Ammolite gemstones and jewelry over the next 12 months, an ambitious goal that its management is optimistic will be achieved (https://ibn.fm/UptJu). By producing its own gold, GEMXX looks to significantly reduce the cost of goods for its entire production line while bolstering the Ammolite segment.

This milestone demonstrates GEMXX’s commitment to creating shareholder value and its unique market positioning, specifically in the Ammolite gemstone mine-to-market segment. As the year progresses, the company looks to ramp up processing to 1,000 cubic yards of gold-bearing ore daily, ultimately enhancing its profitability and stamping its position as a market leader.

Those interested in participating through Reg A financing are encouraged to visit the company’s investor page (https://ibn.fm/oZND6) or contact company officials for more information (ir@gemxx.com – 702-930-1815).

For more information, visit the company’s website at www.GEMXX.com.

NOTE TO INVESTORS: The latest news and updates relating to GEMZ are available in the company’s newsroom at https://ibn.fm/GEMZ

About TinyGems

TinyGems is a specialized communications platform with a focus on innovative small-cap and mid-cap companies with bright futures and huge potential. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, TinyGems is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, TinyGems brings its clients unparalleled recognition and brand awareness. TinyGems is where breaking news, insightful content and actionable information converge.

To receive SMS alerts from TinyGems, text “Gems” to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.TinyGems.com

Please see full terms of use and disclaimers on the TinyGems website applicable to all content provided by TinyGems, wherever published or re-published: https://www.TinyGems.com/Disclaimer

TinyGems
Los Angeles, CA
www.TinyGems.com
310.299.1717 Office
Editor@TinyGems.com

TinyGems is powered by IBN

Christian Amiscua

Share
Published by
Christian Amiscua

Recent Posts

LIXTE Biotechnology Holdings Inc. (NASDAQ: LIXT) Advances PP2A Inhibition Strategy in Evolving Oncology Landscape

Recent research shows how chemotherapy and immunotherapy can complement each other when used together. Within…

9 hours ago

Scientists Discover Why Colon Cancer Diagnoses are Increasing in Young Adults

Researchers have found that people under 50 who develop colorectal cancer have unusually rigid colon tissue that helps tumors…

2 days ago

US Military Admits it is Using AI in Attacks Against Iran

The U.S. military has confirmed that AI systems are actively involved in its ongoing operations against Iran, an admission that…

4 days ago

Investing in Innovation: Evaluating the Clinical and Commercial Potential of LB-100 and Liora’s Proton Therapy

LIXTE Biotechnology Holdings and Liora Technologies recently joined forces to soon offer a real fight…

4 days ago

LIXTE Biotechnology Holdings Inc. (NASDAQ: LIXT) Expands LB 100 Development Through Strategic Academic and Pharma Partnerships

LIXTE recently expanded its ovarian clear cell cancer trial in partnership with MD Anderson and…

1 week ago

Researchers Trace Differing Pediatric Brain Tumors to Common Source

New research has uncovered a shared biological weakness running across three distinct pediatric brain cancers, a finding…

1 week ago